Once they establish a dominant position with both DCVax's, I see no reason that FlaskWorks couldn't either be used by others in making non-competitive personalized products, or be spun off as a separate company with all NWBO shareholders receiving shares.
One of core business could be that NWBO provides DCVax-L as a platform to both the public and private sectors so that they can identify potential targets that can loaded on the bio missiles like ADCs and t-cell engagers to treat various types of cancers.
Market Data 
Markets 
